1-6 of 6
Chunyan Yue
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome of bridging therapy in chimeric antigen receptor T cell treatment for Relapsed/Refractory B-cell non-Hodgkin lymphoma: A retrospective study.

Free
Sanfang Tu, Langqi Wang, Shaojie Wu, Yanjie He, Chaoyang Song, Zhao Liang, Xuan Zhou, Lei Wang, Chunyan Yue, Lijuan Zhou, Jilong Yang, Yuhua Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 8045.
https://doi.org/10.1182/blood-2025-8045
Published: 2025
Journal Articles

Deeper remission achievement and longer leukemia-free survival with inati-cel as consolidation therapy in allogeneic transplant-ineligible adolescent and adult patients with B-ALL

Free
Sanfang Tu, Kaixin Ou, Lei Wang, Xuan Zhou, Chaoyang Song, Shaojie Wu, Rui Huang, Yanjie He, Yuxian Huang, Chunyan Yue, Minhong Huang, Yuhua Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 3353.
https://doi.org/10.1182/blood-2025-3353
Published: 2025
Journal Articles

Retrospective analysis of 30mg/kg ATLG in preventing GVHD after haploidentical hematopoietic stem cell transplantation

Free
Sanfang Tu, Minhong Huang, Chaoyang Song, Yuxian Huang, Rui Huang, Yanjie He, Shaojie Wu, Xuan Zhou, Jilong Yang, Chunyan Yue, Lei Wang, Yuhua Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 7754.
https://doi.org/10.1182/blood-2025-7754
Published: 2025
Journal Articles

Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Trial

Free
Chuting Yang, Yaling Zheng, Chaoyang Song, Ming Wu, Lei Wang, Xuan Zhou, Chunyan Yue, Xiaonan Lin, Jie Chen, Hui Zeng, Rui Huang, Yuhua Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 7045.
https://doi.org/10.1182/blood-2023-174879
Published: 2023
Journal Articles

Therapy of 4s Chimeric Antigen Receptor T Cells Achieves Long-Term Disease-Free Survival with No Severe CRS or Cres in Patients with Relapsed and Refractory Acute Lymphoblastic Leukemia

Free
Sanfang Tu, MD PhD, Rui Huang, MD PhD, Lan Deng, MD PhD, Xuan Zhou, MD, Yanjie He, MD PhD, Weijun Zhou, MD PhD, Jilong Yang, MD, Chunyan Yue, MD, Anqin Wu, Meifang Li, MD PhD, Zhenling Guo, Lung-Ji Chang, PhD, Yuhua Li, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2696.
https://doi.org/10.1182/blood-2018-99-118928
Published: 2018
Journal Articles

A Novel Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD123 to Treat Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Free
Sanfang Tu, MD PhD, Lan Deng, MD PhD, Rui Huang, MD PhD, Xuan Zhou, MD, Jilong Yang, MD, Weijun Zhou, MD PhD, Meifang Li, MD PhD, Chunyan Yue, MD, Shaojie Wu, MD PhD, Zhenling Guo, Lung-Ji Chang, PhD, Yuhua Li, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4015.
https://doi.org/10.1182/blood-2018-99-118526
Published: 2018